These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Further studies on the platelet-inhibitory effect of guanidinosuccinic acid and its role in uremic bleeding. Horowitz HI; Stein IM; Cohen BD; White JG Am J Med; 1970 Sep; 49(3):336-45. PubMed ID: 5455565 [No Abstract] [Full Text] [Related]
4. Mathematical correlation between ADP-induced platelet aggregation and subsequent disaggregation. A parameter for the velocity of disaggregation. Holdrinet A; Ewals M; Reichert WJ; Haanen C Scand J Haematol; 1969; 6(5):354-64. PubMed ID: 5308086 [No Abstract] [Full Text] [Related]
5. Guanidinosuccinic acid on human platelet. Effects of exogenous urea, creatinine, and aggregation in vitro. Davis JW; McField JR; Phillips PE; Graham BA Blood; 1972 Mar; 39(3):388-97. PubMed ID: 5059649 [No Abstract] [Full Text] [Related]
6. Platelet function. Marcus AJ N Engl J Med; 1969 Jun; 280(23):1278-84. PubMed ID: 4890249 [No Abstract] [Full Text] [Related]
8. [The effect of some "uremic toxins" on the renal production of ammonia]. Tizianello A; De Ferrari G; Garibotto G; Gurreri G; Acquarone N; Bruzzone M Minerva Nefrol; 1976; 23(2):79-82. PubMed ID: 1004795 [No Abstract] [Full Text] [Related]
9. On the effect on human thrombocytes of synthetic organic fibrinolytic compounds. Molinas F; von Kaulla KN Thromb Diath Haemorrh; 1969 Feb; 21(1):46-64. PubMed ID: 5773729 [No Abstract] [Full Text] [Related]
10. Variation in ADP-induced platelet aggregation in vitro in primates as a result of differences in plasma ADP inhibitor levels. Hawkey CM; Symons C Thromb Diath Haemorrh; 1968 Mar; 19(1):29-35. PubMed ID: 4968023 [No Abstract] [Full Text] [Related]
11. Kinetic studies of platelet aggregation induced by adenosine diphosphate and its inhibition by chelating agents, guanidino compounds, and adenosine. Skoza L; Zucker MB; Jerushalmy Z; Grant R Thromb Diath Haemorrh; 1967 Dec; 18(3-4):713-25. PubMed ID: 4952980 [No Abstract] [Full Text] [Related]
12. The effects of uremic compounds on cardiac function and metabolism. Scheuer J; Stezoski W J Mol Cell Cardiol; 1973 Jun; 5(3):287-300. PubMed ID: 4720519 [No Abstract] [Full Text] [Related]
13. Uremic bleeding: closing the circle after 30 years of controversies? Noris M; Remuzzi G Blood; 1999 Oct; 94(8):2569-74. PubMed ID: 10515859 [No Abstract] [Full Text] [Related]
14. Energy production and utilization by human platelets in the presence of some guanidines and phenols (uremic toxins) that inhibit aggregation. Carroll HJ Thromb Diath Haemorrh; 1975 Sep; 34(1):63-71. PubMed ID: 1188836 [TBL] [Abstract][Full Text] [Related]
15. Relationships between platelet function tests in normal and uraemic subjects. Hassanein AA; McNicol GP; Douglas AS J Clin Pathol; 1970 Jul; 23(5):402-6. PubMed ID: 5476867 [TBL] [Abstract][Full Text] [Related]
16. [Inhibition of ADP-induced thrombocyte aggregation by adenosine and adenosine derivatives. 1. Quantification of antagonism between ADP and adenosine in vitro]. Birkenheier H; Dietmann K; Schaumann W Arzneimittelforschung; 1970 Oct; 20(10):1569-71. PubMed ID: 5536426 [No Abstract] [Full Text] [Related]
17. The influence of salicylate on platelets and whole blood adenine nucleotides. Davies DT; Hughes A; Tonks RS Br J Pharmacol; 1969 Jul; 36(3):437-47. PubMed ID: 5789804 [TBL] [Abstract][Full Text] [Related]
18. Significance of ADP, plasma and platelet concentration in platelet electrophoretic studies. Betts JJ; Betts JP; Nicholson JT Nature; 1968 Sep; 219(5160):1280-2. PubMed ID: 5677435 [No Abstract] [Full Text] [Related]
19. Role of calcium ions and phospholipids in platelet aggregation and plug formation. Silver MJ Am J Physiol; 1965 Dec; 209(6):1128-36. PubMed ID: 5846913 [No Abstract] [Full Text] [Related]
20. Platelet function in uremia. Cohen BD; Horowitz HI N Engl J Med; 1969 Jun; 280(24):1362-3. PubMed ID: 5783668 [No Abstract] [Full Text] [Related] [Next] [New Search]